Ivabradine

Generic Name
Ivabradine
Brand Names
Corlanor, Lancora, Procoralan, Corlentor, Ivabradine Accord, Ivabradine Anpharm, Ivabradine Zentiva
Drug Type
Small Molecule
Chemical Formula
C27H36N2O5
CAS Number
155974-00-8
Unique Ingredient Identifier
3H48L0LPZQ
Background

Ivabradine is a novel heart rate lowering medicine for the symptomatic management of stable angina pectoralis and symptomatic chronic heart failure. Ivabradine, brand name Corlanor, was approved by the FDA in April 2015 for the treatment of chronic heart failure in patients with an ejection fraction of ≤35%, in sinus rhythm with resting heart rate ≥70 beats ...

Indication

Ivabradine is indicated by the FDA to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤35%, who are in sinus rhythm with resting heart rate ≥70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contrain...

Associated Conditions
Chronic Heart Failure (CHF), Chronic Stable Angina Pectoris, Left Ventricular Dysfunction, Chronic, stable, symptomatic Heart Failure
Associated Therapies
-

Efficacy Study of Digoxin & Ivabradine to Treat Heart Failure

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-10-04
Last Posted Date
2013-11-11
Lead Sponsor
Cocco, Giuseppe, M.D.
Target Recruit Count
22
Registration Number
NCT01699776
Locations
🇨🇭

Cardiology office, Rheinfelden, Argovia, Switzerland

Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia

First Posted Date
2012-08-06
Last Posted Date
2016-09-30
Lead Sponsor
Policlinico Casilino ASL RMB
Target Recruit Count
20
Registration Number
NCT01657136
Locations
🇮🇹

Policlinico Casilino, Rome, Italy

Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol

First Posted Date
2011-08-29
Last Posted Date
2012-06-28
Lead Sponsor
University of Campania "Luigi Vanvitelli"
Target Recruit Count
220
Registration Number
NCT01425164
Locations
🇮🇹

Chair of Cardiology Second University of Naples, Naples, Italy

Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-06-15
Last Posted Date
2012-01-19
Lead Sponsor
University of Campania "Luigi Vanvitelli"
Target Recruit Count
150
Registration Number
NCT01373619
Locations
🇮🇹

Chair of Cardiology Second Univesity of Naples, Naples, Italy

Ivabradine in Hemodialysed Patients With Increased Heart Rate

Phase 4
Conditions
Interventions
First Posted Date
2011-06-02
Last Posted Date
2012-06-21
Lead Sponsor
University of Campania "Luigi Vanvitelli"
Target Recruit Count
100
Registration Number
NCT01364077
Locations
🇮🇹

Chair of Cardiology, Naples, Italy

Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine

First Posted Date
2010-08-23
Last Posted Date
2010-09-08
Lead Sponsor
Martin-Luther-Universität Halle-Wittenberg
Target Recruit Count
70
Registration Number
NCT01186783
Locations
🇩🇪

Department of Medicine III of the University Clinics Halle (Saale) of the Martin-Luther-University Halle-Wittenberg, Halle (Saale), Saxony-Anhalt, Germany

Heart Rate Reduction in Heart Failure

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-08-10
Last Posted Date
2014-09-30
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
121
Registration Number
NCT01178528
Locations
🇮🇹

Centre for Clinical and Basic Research - IRCCS San Raffaele, Roma, Italy

🇮🇹

IRCCS San Raffaele, Roma, Italy

Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-12-25
Last Posted Date
2013-07-12
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
43
Registration Number
NCT01039389
Locations
🇨🇭

Bern University Hospital, Bern, Switzerland

The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals

First Posted Date
2009-12-09
Last Posted Date
2011-11-09
Lead Sponsor
Bayside Health
Target Recruit Count
42
Registration Number
NCT01029223

Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-12-01
Last Posted Date
2011-07-07
Lead Sponsor
Govind Ballabh Pant Hospital
Target Recruit Count
50
Registration Number
NCT01022463
Locations
🇮🇳

G. B. Pant Hospital, New Delhi, Delhi, India

© Copyright 2024. All Rights Reserved by MedPath